Does The Future Of Life Science Manufacturing Say "Made In U.S.A.?"

Source: Life Science Leader

In this executive virtual roundtable (EVR) segment, Louise Perry, SVP Tech Ops, Solid Biosciences, shares her thoughts on biopharmaceutical manufacturing needing to be global in scope, as opposed to nationalistic in nature. Bryan Butman, Ph.D., head of CMC, Precigen; and Tim Valko, head of global manufacturing supply chain, Atara Biotherapeutics; add to the conversation by discussing harmonization and centralized versus decentralized cell therapy manufacturing.